DOC Generici is Italy’s largest independent generic pharmaceutical company. It provides drugs for the treatment of common medical conditions with a broad product portfolio and a strong presence in areas including cardiovascular, gastrointestinal, metabolism and neurological treatments.
The company operates an asset-light model and benefits from a consolidated network of suppliers primarily based in Europe.
Buyout
Divested
Europe
Co-investment
Therapeutic Intervention
2019
Status
Creation Date
Number of Employees
Investment Date
Fund Name